Dopamine-induced changes in renal blood flow in normals and in patients with renal dysfunction

Catheterization and Cardiovascular Interventions

Volumn 72, Issue 5, 2008, Pages 725-730

  Drieghe, Benny ^a   Monoharan, Ganesh ^a   Heyndrickx, Guy R ^a   Madaric, Juraj ^a   Bartunek, Jozef ^a   Sarno, Giovanna ^a   Vanderheyden, Marc ^a   De Bruyne, Bernard ^a  

^a CARDIOVASCULAR CENTER   (Belgium)

Author keywords

Dopamine; Hemodynamics; Renal dysfunction; Renal physiology

Indexed keywords

DOPAMINE;

AGED; ARTICLE; BLOOD FLOW VELOCITY; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; FEMALE; HEART RATE; HUMAN; KIDNEY BLOOD FLOW; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MALE; MEAN ARTERIAL PRESSURE; BLOOD PRESSURE; CLINICAL TRIAL; DRUG EFFECT; HEMODYNAMICS; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY; KIDNEY CIRCULATION; KIDNEY DISEASE; MIDDLE AGED; PATHOPHYSIOLOGY; VASCULAR RESISTANCE; VASCULARIZATION;

AGED; AGED, 80 AND OVER; BLOOD FLOW VELOCITY; BLOOD PRESSURE; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEART RATE; HEMODYNAMICS; HUMANS; INFUSIONS, INTRAVENOUS; KIDNEY; KIDNEY DISEASES; MALE; MIDDLE AGED; RENAL CIRCULATION; VASCULAR RESISTANCE;

EID: 58749095869     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.21741     Document Type: Article

References (24)

1. Denton MD, Chertow GM, Brady HR. "Renal-dose" dopamine for the treatment of acute renal failure: Scientific rationale, experimental studies and clinical trials. Kidney Int 1996;50:4-14.
2. Goldberg LI, Mcdonald RH Jr., Zimmerman AM. Sodium diuresis produced by dopamine in patients with congestive heart failure. N Engl J Med 1963;269:1060-1064.
3. Friedrich JO, Adhikari N, Herridge MS, et al. Meta-analysis: Low-dose dopamine increases urine output but does not prevent renal dysfunction or death. Ann Intern Med 2005;142:510-524.
4. Debaveye YA, Van den Berghe GH. Is there still a place for dopamine in the modern intensive care unit? Anesth Analg 2004; 98:461-468.
5. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
6. Olsen NV. Effects of dopamine on renal haemodynamics tubular function and sodium excretion in normal humans. Dan Med Bull 1998;45:282-297.
7. Felder RA, Felder CC, Eisner GM, et al. The dopamine receptor in adult and maturing kidney. Am J Physiol 1989;257:F315-F327.
8. Horton R, Bughi S, Jost-Vu E, et al. Effect of dopamine on renal blood flow, prostaglandins, renin and electrolyte excretion in normal and hypertensive humans. Am J Hypertens 1990;3:108S-111S.
9. Olsen NV, Lund J, Jensen PF, et al. Dopamine, dobutamine, and dopexamine. A comparison of renal effects in unanesthetized human volunteers. Anesthesiology 1993;79:685-694.
10. Smit AJ. Dopamine in chronic renal failure. Am J Hypertens 1990;3:75S-77S.
11. Kuchel OG, Shigetomi S. Dopaminergic abnormalities in hypertension associated with moderate renal insufficiency. Hypertension 1994;23:I240-I245.
12. D'Orio V, el Allaf D, Juchmes J, et al. The use of low-dose dopamine in intensive care medicine. Arch Int Physiol Biochim Biophys 1984;92:S11-S20.
13. Power DA, Duggan J, Brady HR. Renal-dose (low-dose) dopamine for the treatment of sepsis-related and other forms acute renal failure: Ineffective and probably dangerous. Clin Exp Pharmacol Physiol Suppl 1999;26:S23-28.
14. Lassnigg A, Donner E, Grubhofer G, et al. Lack of renoprotective effects of dopamine and furosemide during cardiac surgery. J Am Soc Nephrol 2000;11:97-104.
15. Bellomo R, Chapman M, Finfer S, et al. Low-dose dopamine in patients with early renal dysfunction: A placebo-controlled randomised trial: Australian and New Zealand intensive care society (ANZICS) clinical trials group. Lancet 2000;356:2139-2143.
16. Holmes CL, Walley KR. Bad medicine: Low- dose dopamine in the ICU. Chest 2003;123:1266-1275.
17. Lauschke A, Teichgraber UK, Frei U, et al. 'Low-dose' dopamine worsens renal perfusion in patients with acute renal failure. Kidney Int 2006;69:1669-1674.
18. Brienza N, Malcangi V, Dalfino L, et al. A comparison between fenoldopam and low-dose dopamine in early renal dysfunction of critically ill patients. Crit Care Med 2006;34:707-714.
19. Stone GW, Mc Cullough PA, Tumlin JA, et al. For the CONTRAST investigators. Fenodopam mesylate for the prevention of contrast-induced nephropathy: A randomized controlled trial. JAMA 2003;290:2284-2291.
20. Teirstein PS, Price MJ, Mathur VS, et al. Differential effects between intravenous and targeted renal delivery of fenoldopam on renal function and blood pressure in patients undergoing cardiac catheterization. Am J Cardiol 2006;97:1076-1081.
21. Gare M, Haviv YS, Ben-Yehuda A, et al. The renal effect of low-dose dopamine in high-risk patients undergoing coronary angiography. J Am Coll Cardiol 1999;34:1682-1688.
22. Abizaid AS, Clark CE, Mintz GS, et al. Effects of dopamine and aminophylline on contrast-induced acute renal failure after coronary angioplasty in patients with pre-existing renal insufficiency. Am J Cardiol 1999;83:260-263.
23. Mulkerrin E, Epstein FH, Clark BA. Reduced renal response to low-dose dopamine infusion in the elderly. J Gerontol A Biol Sci Med Sci 1995;50:M271-M275.
24. Fuiano G, Sund S, Mazza G, et al. Renal hemodynamic response to maximal vasodilating stimulus in healthy older subjects. Kidney Int 2001;59:1052-1058.